Ab­b­Vie makes an­oth­er small I&I ac­qui­si­tion, buy­ing Nim­ble for $200M

In an at­tempt to con­tin­ue its I&I dom­i­nance be­yond Hu­mi­ra, Skyrizi and Rin­voq, Ab­b­Vie is buy­ing up an­oth­er small au­toim­mune start­up.

The Chica­go-area phar­ma gi­ant …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER